14 Einträge gefunden

1. Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry-Comparison of Three Different GPA Prognostic Scores

   1. Riecke, Kerstin
   2. Müller, Volkmar
   3. Weide, Rudolf
   4. Schmidt, Marcus
   5. Park-Simon, Tjoung-Won
   6. Möbus, Volker
   7. Mundhenke, Christoph

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
2. AGO Algorithms for the Treatment of Breast Cancer: Update 2021

   1. Schneeweiss, Andreas
   2. Fasching, Peter A
   3. Fehm, Tanja
   4. Gerber, Bernd
   5. Jackisch, Christian
   6. Loibl, Sibylle
   7. Schmidt, Marcus

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
3. AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2017

   1. Thill, Marc
   2. Liedtke, Cornelia
   3. Solomayer, Erich-Franz
   4. Müller, Volkmar
   5. Janni, Wolfgang
   6. Schmidt, Marcus

   2017 - Forschungsinformationssystem des UKE
4. Systemic Treatment Options for HER2-Positive Breast Cancer Patients with Brain Metastases beyond Trastuzumab: A Literature Review

   1. Laakmann, Elena
   2. Müller, Volkmar
   3. Schmidt, Marcus
   4. Witzel, Isabell

   2017 - Forschungsinformationssystem des UKE
5. News from ASCO 2017

   1. Schmidt, Marcus
   2. Fehm, Tanja
   3. Liedtke, Cornelia
   4. Müller, Volkmar

   2017 - Forschungsinformationssystem des UKE
6. Control of dataset bias in combined Affymetrix cohorts of triple negative breast cancer

   1. Karn, Thomas
   2. Rody, Achim
   3. Müller, Volkmar
   4. Schmidt, Marcus
   5. Becker, Sven
   6. Holtrich, Uwe
   7. Pusztai, Lajos

   2014 - Forschungsinformationssystem des UKE - frei zugänglich
7. Prognostic relevance of glycosylation-associated genes in breast cancer

   1. Milde-Langosch, Karin
   2. Karn, Thomas
   3. Schmidt, Marcus
   4. Zu Eulenburg, Christine
   5. Oliveira Ferrer, Leticia
   6. Wirtz, Ralph M
   7. Schumacher, Udo

   2014 - Forschungsinformationssystem des UKE
8. Role of urokinase plasminogen activator and plasminogen activator inhibitor mRNA expression as prognostic factors in molecular subtypes of breast cancer

   1. Witzel, Isabell
   2. Milde-Langosch, Karin
   3. Schmidt, Marcus
   4. Karn, Thomas
   5. Becker, Sven
   6. Wirtz, Ralph
   7. Rody, Achim

   2014 - Forschungsinformationssystem des UKE - frei zugänglich
9. Relevance of cellular and serum carbonic anhydrase IX in primary breast cancer

   1. Schütze, Dina
   2. Milde-Langosch, Karin
   3. Witzel, Isabell
   4. Rody, Achim
   5. Karn, Thomas
   6. Schmidt, Marcus
   7. Choschzick, Matthias

   2013 - Forschungsinformationssystem des UKE
10. Weekly nab-Paclitaxel in Metastatic Breast Cancer - Summary and Results of an Expert Panel Discussion.

    1. Jackisch, Christian
    2. Lück, Hans-Joachim
    3. Untch, Michael
    4. Bischoff, Joachim
    5. Müller, Volkmar
    6. Schmidt, Marcus
    7. Thill, Marc

    2012 - Forschungsinformationssystem des UKE
11. Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentation.

    1. Karn, Thomas
    2. Pusztai, Lajos
    3. Ruckhäberle, Eugen
    4. Liedtke, Cornelia
    5. Müller, Volkmar
    6. Schmidt, Marcus
    7. Metzler, Dirk

    2012 - Forschungsinformationssystem des UKE
12. Gene expression profiling of luminal B breast cancers reveals NHERF1 as a new marker of endocrine resistance.

    1. Karn, Thomas
    2. Ruckhäberle, Eugen
    3. Hanker, Lars
    4. Müller, Volkmar
    5. Schmidt, Marcus
    6. Solbach, Christine
    7. Gätje, Regine

    2011 - Forschungsinformationssystem des UKE
13. Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures.

    1. Karn, Thomas
    2. Pusztai, Lajos
    3. Holtrich, Uwe
    4. Iwamoto, Takayuki
    5. Shiang, Christine Y
    6. Schmidt, Marcus
    7. Müller, Volkmar

    2011 - Forschungsinformationssystem des UKE - frei zugänglich
14. Final results of a phase I/II pilot study of capecitabine with or without vinorelbine after sequential dose-dense epirubicin and paclitaxel in high-risk early breast cancer.

    1. Müller, Volkmar
    2. Thomssen, Christoph
    3. Schmidt, Marcus
    4. Glados, Manfred
    5. Jackisch, Christian
    6. Heilmann, Volker
    7. Hinke, Axel

    2010 - Forschungsinformationssystem des UKE - frei zugänglich